Klinički bolnički centar Osijek

Az itteni vizsgálatok

Miről szól a helyszín 44 vizsgálata, a regiszteri adatlapjaik szerint.

Betegségek

• Sclerosis multiplex (SM)5 vizsgálat
• 2-es típusú cukorbetegség4 vizsgálat
• Arthritis psoriatica4 vizsgálat
• Időskori makuladegeneráció4 vizsgálat
• Pikkelysömör4 vizsgálat
• Sjögren-szindróma3 vizsgálat
• Colitis ulcerosa2 vizsgálat
• Diabéteszes retinopátia2 vizsgálat
• Szisztémás szklerózis (szkleroderma)2 vizsgálat
• Tüdőrák2 vizsgálat
• Alzheimer-kór1 vizsgálat
• Crohn-betegség1 vizsgálat
• és még 14

Fázis

• 3. fázis37 vizsgálat
• 2. fázis3 vizsgálat
• 2/3. fázis3 vizsgálat
• 4. fázis1 vizsgálat

Állapot

• Fut, nem toboroz17 vizsgálat
• Lezárult13 vizsgálat
• Toboroz12 vizsgálat
• Még nem toboroz2 vizsgálat

Fő szponzor

• Novo Nordisk A/S5 vizsgálat
• Amgen3 vizsgálat
• AbbVie2 vizsgálat
• Alfasigma S.p.A.2 vizsgálat
• Boehringer Ingelheim2 vizsgálat
• és még 27

Futó vizsgálatok

• Még nem toboroz

  AMBITION 3: A Research Study Investigating How Well Zenagamtide at Higher Dose Levels Lowers Blood Sugar and Body Weight Compared to Semaglutide in People With Type 2 Diabetes Treated With Metformin, SGLT2i, or Both

  NCT07931573· 3. fázis· Novo Nordisk A/S· Forrás

• Toboroz

  A Study to Test Whether Nerandomilast Helps People With Systemic Sclerosis

  NCT07497087· 3. fázis· Boehringer Ingelheim· Forrás

• Toboroz

  A clinical trial of EYE201/MK-8748 in people with macular degeneration (MK-8748-003)

  2025-524894-17-00· 2/3. fázis· Eyebiotech Limited· Forrás

• Toboroz

  A clinical trial to find out how well LOU064 (remibrutinib) works and how safe it is for people with secondary progressive multiple sclerosis

  2025-521546-23-00· 3. fázis· Novartis Pharma AG· Forrás

• Toboroz

  A Study to Test Whether Different Doses of BI 3000202 Help People With Systemic Lupus Erythematosus (SLE)

  NCT07409181· 2. fázis· Boehringer Ingelheim· Forrás

• Toboroz

  Continuation Study of Zasocitinib in Adults With Psoriatic Arthritis

  NCT07286058· 3. fázis· Takeda· Forrás

• Toboroz

  A Study Evaluating the Effects of Filgotinib in Children and Teenagers With Ulcerative Colitis

  NCT06865417· 3. fázis· Alfasigma S.p.A.· Forrás

  Contact: Vlatka Konjik, MD

• Toboroz

  A Study to Evaluate the Efficacy and Safety of DNTH103 in Adults with Chronic Inflammatory Demyelinating Polyneuropathy (CAPTIVATE)

  2024-517529-26-00· 3. fázis· Dianthus Therapeutics Inc.· Forrás

• Toboroz

  A Study to Evaluate the Efficacy and Safety of KarXT + KarX-EC for Cognitive Impairment in Alzheimer's Disease

  NCT06976216· 3. fázis· Bristol-Myers Squibb· Forrás

• Toboroz

  A study evaluating the effects of filgotinib in children and teenagers with ulcerative colitis

  2024-511458-32-00· 3. fázis· Alfasigma S.p.A.· Forrás

• Toboroz

  Multi-center Trial of Ferric Derisomaltose Versus no Intravenous Iron in Iron-deficient Subjects With Symptomatic Chronic Heart Failure

  NCT06929806· 3. fázis· Pharmacosmos A/S· Forrás

• Toboroz

  A Study of Adagrasib Plus Pembrolizumab Plus Chemotherapy vs. Placebo Plus Pembrolizumab Plus Chemotherapy in Participants With Previously Untreated Non-squamous Non-small Cell Lung Cancer With KRAS G12C Mutation (KRYSTAL-4)

  NCT06875310· 3. fázis· Mirati Therapeutics Inc.· Forrás

• Fut, nem toboroz

  A Study of 2 Doses of Remigromig (EYE103) Compared With Ranibizumab (0.5 mg) in Participants With DME

  NCT06957080· 2/3. fázis· EyeBiotech Ltd.· Forrás

• Fut, nem toboroz

  A Study of Zasocitinib in Adults With Psoriatic Arthritis Who Have Not Taken Biologic Medicines

  NCT06671483· 3. fázis· Takeda· Forrás

• Toboroz

  A Long-term Extension Study of Dazodalibep in Participants With Sjögren's Syndrome (SS)

  NCT06747949· 3. fázis· Amgen· Forrás

• Fut, nem toboroz

  A randomized study to evaluate the Efficacy and Safety of Intravitreal EYE103 Compared to Anti-VEGF (in patients with Diabetic Macular Edema)

  2024-510944-30-00· 2/3. fázis· Eyebiotech Limited· Forrás

• Fut, nem toboroz

  A Study to Assess the Efficacy and Safety of Efgartigimod PH20 SC in Adults With Systemic Sclerosis

  NCT06655155· 2. fázis· argenx· Forrás

• Fut, nem toboroz

  A Phase 3 Study to Evaluate Petosemtamab Plus Pembrolizumab vs Pembrolizumab in First-line Treatment of Head and Neck Cancer (LiGeR - HN1)

  NCT06525220· 3. fázis· Genmab· Forrás

• Fut, nem toboroz

  A Study of Subcutaneously Injected Epcoritamab Plus Oral Lenalidomide Capsules Compared to Intravenously (IV) Infused Rituximab Plus IV Infused Gemcitabine and IV Infused Oxaliplatin in Adult Participants With Relapsed or Refractory Diffuse Large B-Cell Lymphoma

  2024-510965-41-00· 3. fázis· AbbVie Deutschland GmbH & Co. KG· Forrás

• Fut, nem toboroz

  A Study to Assess Disease Activity and Safety of Lutikizumab in Adult and Adolescent Participants With Moderate to Severe Hidradenitis Suppurativa

  NCT06468228· 3. fázis· AbbVie· Forrás

• Toboroz

  MagnetisMM-32: A Study to Learn About the Study Medicine Called Elranatamab in People With Multiple Myeloma (MM) That Has Come Back After Taking Other Treatments (Including Prior Treatment With an Anti-CD38 Antibody and Lenalidomide)

  NCT06152575· 3. fázis· Pfizer· Forrás

• Fut, nem toboroz

  A Study to Evaluate ABP 206 Compared With OPDIVO® (Nivolumab) in Subjects With Unresectable or Metastatic Melanoma

  NCT06054555· 3. fázis· Amgen· Forrás

• Toboroz

  Study to evaLuate the effIcacy and Safety of abeLacimab in High-risk Patients With Atrial Fibrillation Who Have Been Deemed Unsuitable for Oral antiCoagulation (LILAC-TIMI 76)

  NCT05712200· 3. fázis· Anthos Therapeutics, Inc.· Forrás

• Fut, nem toboroz

  Efficacy and Safety of Remibrutinib Compared to Teriflunomide in Participants With Relapsing Multiple Sclerosis (RMS) (REMODEL-1)

  NCT05147220· 3. fázis· Novartis Pharmaceuticals· Forrás

• Fut, nem toboroz

  A Study of Guselkumab in Participants With Active Psoriatic Arthritis

  NCT04882098· 3. fázis· Janssen Research & Development, LLC· Forrás

• Fut, nem toboroz

  Research Study on Whether Semaglutide Works in People With Non-alcoholic Steatohepatitis (NASH)

  NCT04822181· 3. fázis· Novo Nordisk A/S· Forrás

• Fut, nem toboroz

  A Long-term Extension Study of Mirikizumab (LY3074828) in Participants With Crohn's Disease

  NCT04232553· 3. fázis· Eli Lilly and Company· Forrás

• Fut, nem toboroz

  An Extension Study of Ublituximab in Participants With Relapsing Multiple Sclerosis

  NCT04130997· 3. fázis· TG Therapeutics, Inc.· Forrás

• Fut, nem toboroz

  A Study to Evaluate the Efficacy and Safety of Ocrelizumab in Adults With Primary Progressive Multiple Sclerosis

  NCT04035005· 3. fázis· Hoffmann-La Roche· Forrás

• Fut, nem toboroz

  An open-label extension study evaluating long-term safety, tolerability and effectiveness of ofatumumab in subjects with RMS

  2023-507906-15-00· 3. fázis· Novartis Pharma AG· Forrás

• Fut, nem toboroz

  A Study of Two Different Doses of Cabozantinib (XL184) in Progressive, Metastatic Medullary Thyroid Cancer

  NCT01896479· 4. fázis· Exelixis· Forrás

Egyszerre toboroz

Hány vizsgálat toboroz itt egyszerre ugyanarra az indikációra. Darabszám, nem értékelés.

• Colitis ulcerosa2 toboroz
• 2-es típusú cukorbetegség1 toboroz
• Alzheimer-kór1 toboroz
• Arthritis psoriatica1 toboroz
• Időskori makuladegeneráció1 toboroz
• Krónikus gyulladásos demielinizációs polineuropátia (CIDP)1 toboroz
• Lupus (SLE)1 toboroz
• Mielóma multiplex1 toboroz
• Pikkelysömör1 toboroz
• Pitvarfibrilláció1 toboroz
• Sclerosis multiplex (SM)1 toboroz
• Szisztémás szklerózis (szkleroderma)1 toboroz
• Szívelégtelenség1 toboroz
• Tüdőrák1 toboroz

Lezárt vizsgálatok

• Fut, nem toboroz

  Study of Eftilagimod Alfa (Efti) in Combination With Pembrolizumab and Chemotherapy Versus Placebo in Combination With Pembrolizumab and Chemotherapy in Participants With Metastatic Non-Small Cell Lung Cancer (NSCLC) (TACTI-004)

  NCT06726265· 3. fázis· Immutep S.A.S.· Forrás

• Lezárult

  A Research Study Comparing How Well Different Doses of the Medicine NNC0487-0111 Lower Blood Sugar in People With Type 2 Diabetes

  NCT06542874· 2. fázis· Novo Nordisk A/S· Forrás

• Lezárult

  A study to find how well Dazodalibep works and how safe it is in participants with Sjögren’s Syndrome

  2023-503923-24-00· 3. fázis· Horizon Therapeutics Ireland Designated Activity Company· Forrás

• Lezárult

  A Clinical Trial to compare Efficacy, Safety, Tolerability of RBS-001 to Eylea® in Subjects with Neovascular Age-Related Macular Degeneration

  2023-509206-29-00· 3. fázis· Rophibio Inc.· Forrás

• Lezárult

  A Study to Evaluate the Efficacy and Safety of Dazodalibep in Participants With Sjögren's Syndrome (SS) With Moderate-to-severe Systemic Disease Activity

  NCT06104124· 3. fázis· Amgen· Forrás

• Lezárult

  Avacincaptad Pegol Open-Label Extension for Patients With Geographic Atrophy

  NCT05536297· 3. fázis· Astellas Pharma Global Development, Inc.· Forrás

• Lezárult

  A Research Study to See How Well the New Weekly Medicine IcoSema, Which is a Combination of Insulin Icodec and Semaglutide, Controls Blood Sugar Level in People With Type 2 Diabetes Compared to Weekly Insulin Icodec

  NCT05352815· 3. fázis· Novo Nordisk A/S· Forrás

• Lezárult

  A clinical study of OPT-302 with aflibercept compared to aflibercept alone in patients with neovascular age-related macular degeneration

  NCT04757636· 3. fázis· Opthea Limited· Forrás

• Lezárult

  The efficacy and safety of two doses of CHF6001 DPI as add-on to maintenance COPD triple therapy

  NCT04636814· 3. fázis· Chiesi Farmaceutici S.p.A.· Forrás

• Lezárult

  A Heart Disease Study of Semaglutide in Patients With Type 2 Diabetes

  NCT03914326· 3. fázis· Novo Nordisk A/S· Forrás

• Lezárult

  Acute-On-Chronic Liver Failure (ACLF) at High Risk of Hospital Mortality

  NCT03702920· 3. fázis· Instituto Grifols S.A.· Forrás

• Fut, nem toboroz

  A Study Comparing Risankizumab to Placebo in Participants With Active Psoriatic Arthritis (PsA) Who Have a History of Inadequate Response to or Intolerance to at Least One Disease Modifying Anti-Rheumatic Drug (DMARD) Therapy

  NCT03675308· 3. fázis· AbbVie· Forrás

• Lezárult

  A Study of the Effect and Safety of Sparsentan in the Treatment of Patients With IgA Nephropathy

  NCT03762850· 3. fázis· Travere Therapeutics, Inc.· Forrás